DIN 02172755 — OMNIPAQUE 350 755 MG
OMNIPAQUE 350 is a solution of Iohexol marketed by GE HEALTHCARE CANADA INC. The full Iohexol monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02172755
- Brand name
- OMNIPAQUE 350
- Active ingredient
- Iohexol
- Strength
- 755 MG
- Dosage form
- SOLUTION
- Route
- INTRAVASCULAR; ORAL
- Manufacturer
- GE HEALTHCARE CANADA INC
- Health Canada status
- MARKETED
- Drug class
- Non-ionic, low-osmolality iodinated radiographic contrast medium
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Iohexol products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02172739 | OMNIPAQUE 240 | 518 MG | SOLUTION | GE HEALTHCARE CANADA INC | MARKETED |
| 02172747 | OMNIPAQUE 300 | 647 MG | SOLUTION | GE HEALTHCARE CANADA INC | MARKETED |